Develop a Risk-Based Monitoring (RBM) plan aligned with FDA's 2013 Oversight of Clinical Investigations guidance and ICH E6(R3) for a specific clinical trial.
All Clinical Monitoring & Risk-Based Management agents · All Clinical Trials & Regulatory Affairs agents